
Prevalence and sociodemographic correlates of medication intake adherence among primary health-care users in Albania / Dajana Roshi;Genc Burazeri;Salvatore Italia;Peter Schröder-Bäck;Alban Ylli;Helmut Brand
Tác giả : Dajana Roshi;Genc Burazeri;Salvatore Italia;Peter Schröder-Bäck;Alban Ylli;Helmut Brand
Nhà xuất bản : World Health Organization. Regional Office for the Eastern Mediterranean
Năm xuất bản : 2021
Chủ đề : 1. Cross-Sectional Studies. 2. Health Care Costs. 3. Medication Adherence. 4. Pharmaceutical Products. 5. Prevalence. 6. Primary Health Care. 7. Surveys and Questionnaires. 8. Journal / periodical articles.
Thông tin chi tiết
Tóm tắt : | Background: Evidence about the magnitude and determinants of medication intake adherence among patients and the general population in Southeastern Europe is scant. Aims: To assess the prevalence and sociodemographic correlates of medication intake adherence among adult primary healthcare (PHC) users in Albania. Methods: A cross-sectional study was conducted in 2018–2019 in a representative sample of 1553 adult PHC users (response: 94%) selected probabilistically from 5 major regions of Albania. There were 849 (55%) women and 704 (45%) men, with a mean age 54.6 (16.4) years. A structured interviewer-administered questionnaire inquired about medication intake adherence prescribed by family physicians, and sociodemographic characteristics. Binary logistic regression was used to assess the sociodemographic correlates of medication intake adherence. Results: Three hundred (19.8%) participants did not take the prescribed medication. In multivariable-adjusted logistic model, significant correlates of nonintake of medication included rural residence, low educational level, unemployment and low economic level. Among these 300 participants, 273 (91%) considered the high cost of the drugs as a reason for not taking the medication. Conclusion: We found a high prevalence of nonintake of medication prescribed by family physicians. Decision-makers and policymakers in Albania and elsewhere should consider the provision of essential drugs free of charge or at low cost to low socioeconomic groups and other vulnerable and marginalized population categories, because the costs of noncompliance will eventually be higher. |
Thông tin dữ liệu nguồn
Thư viện | Ký hiệu xếp giá | Dữ liệu nguồn |
---|---|---|
![]() |
|
https://iris.who.int/handle/10665/352818 |